Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
59 results
  • Lung Cancer

19-368          Phase II

A Biomarker-Directed Phase 2 Platform Study in Patients with Advanced Non-Small Cell Lung Cancer whose Disease has Progressed on First-Line Osimertinib Therapy (ORCHARD) (View details on clinicaltrial.gov)

  • Lung Cancer

19-103          Phase I

A first-in-human study for the evaluation of the safety, pharmacokinetics and antitumor activity of SAR408701 in patients with advanced solid tumors (View details on clinicaltrial.gov)

  • Melanoma, Lung Cancer, Head and Neck Cancer, Bladder Cancer

18-418          Phase III

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial. (View details on clinicaltrial.gov)

  • Melanoma, Lung Cancer, Colorectal Cancer

17-607          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Endometrial Cancer, Breast Cancer, Ovarian Cancer

16-393          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Bladder Cancer, Cellular Therapy, Metastatic/Advanced Cancer

17-553          Phase I

A Phase 1 Study Evaluating the Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Subjects with Advanced Cancers (View details on clinicaltrial.gov)

  • Lung Cancer, Colorectal Cancer, Melanoma, Pancreatic Cancer

16-456          Phase I

A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination with Other Agents in Advanced Cancer (View details on clinicaltrial.gov)

  • Lung Cancer

19-037          Phase I

A Phase 1 Study of SC-011 as a Single-Agent and in Combination with ABBV-181 in Subjects with Relapsed or Refractory Small Cell Lung Cancer (View details on clinicaltrial.gov)

  • Lung Cancer, Head and Neck Cancer

17-002          Phase I

A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 59 results